@article{discovery1437467,
           pages = {2881.e1--2881.e6},
           month = {December},
          volume = {35},
            year = {2014},
          number = {12},
            note = {Copyright {\copyright} 2014 Elsevier Inc. Article available under CC BY licence},
         journal = {Neurobiology of Aging},
           title = {Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease},
        keywords = {APP, Alzheimer's disease, Exome sequencing, GRN, MAPT, Neurodegenerative dementia, PRNP, PSEN1, PSEN2, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid beta-Protein Precursor, Cohort Studies, Dementia, Diagnosis, Differential, Female, Genetic Association Studies, Genetic Predisposition to Disease, Genetic Testing, Genetic Variation, Humans, Intercellular Signaling Peptides and Proteins, Male, Middle Aged, Presenilin-1, Presenilin-2, Prions, tau Proteins},
            issn = {1558-1497},
        abstract = {The overlapping clinical and neuropathologic features between late-onset apparently sporadic Alzheimer's disease (LOAD), familial Alzheimer's disease (FAD), and other neurodegenerative dementias (frontotemporal dementia, corticobasal degeneration, progressive supranuclear palsy, and Creutzfeldt-Jakob disease) raise the question of whether shared genetic risk factors may explain the similar phenotype among these disparate disorders. To investigate this intriguing hypothesis, we analyzed rare coding variability in 6 Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP), in 141 LOAD patients and 179 elderly controls, neuropathologically proven, from the UK. In our cohort, 14 LOAD cases (10\%) and 11 controls (6\%) carry at least 1 rare variant in the genes studied. We report a novel variant in PSEN1 (p.I168T) and a rare variant in PSEN2 (p.A237V), absent in controls and both likely pathogenic. Our findings support previous studies, suggesting that (1) rare coding variability in PSEN1 and PSEN2 may influence the susceptibility for LOAD and (2) GRN, MAPT, and PRNP are not major contributors to LOAD. Thus, genetic screening is pivotal for the clinical differential diagnosis of these neurodegenerative dementias.},
          author = {Sassi, C and Guerreiro, R and Gibbs, R and Ding, J and Lupton, MK and Troakes, C and Al-Sarraj, S and Niblock, M and Gallo, JM and Adnan, J and Killick, R and Brown, KS and Medway, C and Lord, J and Turton, J and Bras, J and Alzheimer's Research UK Consortium, {} and Morgan, K and Powell, JF and Singleton, A and Hardy, J},
             url = {http://dx.doi.org/10.1016/j.neurobiolaging.2014.06.002}
}